Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Oral solid dosage forms are the most commonly used pharmaceuticals to treat various disease conditions. Oral solid dosage forms are cost-effective and easy to manufacture in comparison with other dosage forms. They offer significant benefits to manufacturers such as trouble free packaging and transportation and increased chemical and physical stability. Oral solids offer many advantages to patients as well.
North America dominated the global oral solid dosage pharmaceutical formulation market in revenue terms in 2017, and the trend is projected to continue throughout the forecast period.
The report details the trend, potential and market size of Oral Solid Dosage Pharmaceutical Formulation market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Oral Solid Dosage Pharmaceutical Formulationmarket, defines the market attractiveness level of Oral Solid Dosage Pharmaceutical Formulation market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Oral Solid Dosage Pharmaceutical Formulation industry, describes the types of Oral Solid Dosage Pharmaceutical Formulation market, the applications of major players and the market size, and deeply analyzes the current situation of the global Oral Solid Dosage Pharmaceutical Formulation market and the development prospects and opportunities of Oral Solid Dosage Pharmaceutical Formulation industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Oral Solid Dosage Pharmaceutical Formulation market in Chapter 13.
By Player:
Gilead
AbbVie
AstraZeneca
Eli Lilly
Novartis
Pfizer
Merck
Boehringer Ingelheim
Bristol-Myers Squibb
By Type:
Immediate Release
Extended Release
Others
By End-User:
Hospital Pharmacy
Retail Pharmacy
Drug Stores
Others
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Oral Solid Dosage Pharmaceutical Formulation Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Oral Solid Dosage Pharmaceutical Formulation Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Oral Solid Dosage Pharmaceutical Formulation Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Oral Solid Dosage Pharmaceutical Formulation Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Oral Solid Dosage Pharmaceutical Formulation Market Analysis and Outlook to 2022
-
7.1 Global Oral Solid Dosage Pharmaceutical Formulation Consumption (2017-2022)
-
7.2 United States Oral Solid Dosage Pharmaceutical Formulation Consumption (2017-2022)
-
7.3 Europe Oral Solid Dosage Pharmaceutical Formulation Consumption (2017-2022)
-
7.4 China Oral Solid Dosage Pharmaceutical Formulation Consumption (2017-2022)
-
7.5 Japan Oral Solid Dosage Pharmaceutical Formulation Consumption (2017-2022)
-
7.6 India Oral Solid Dosage Pharmaceutical Formulation Consumption (2017-2022)
-
7.7 South Korea Oral Solid Dosage Pharmaceutical Formulation Consumption (2017-2022)
8 Region and Country-wise Oral Solid Dosage Pharmaceutical Formulation Market Analysis and Outlook to 2028
-
8.1 Global Oral Solid Dosage Pharmaceutical Formulation Consumption Forecast (2022-2028)
-
8.2 United States Oral Solid Dosage Pharmaceutical Formulation Consumption Forecast (2022-2028)
-
8.3 Europe Oral Solid Dosage Pharmaceutical Formulation Consumption Forecast (2022-2028)
-
8.4 China Oral Solid Dosage Pharmaceutical Formulation Consumption Forecast (2022-2028)
-
8.5 Japan Oral Solid Dosage Pharmaceutical Formulation Consumption Forecast (2022-2028)
-
8.6 India Oral Solid Dosage Pharmaceutical Formulation Consumption Forecast (2022-2028)
-
8.7 South Korea Oral Solid Dosage Pharmaceutical Formulation Consumption Forecast (2022-2028)
9 Global Oral Solid Dosage Pharmaceutical Formulation Market Outlook by Types and Applications to 2022
-
9.1 Global Oral Solid Dosage Pharmaceutical Formulation Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Immediate Release Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Extended Release Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global Oral Solid Dosage Pharmaceutical Formulation Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospital Pharmacy Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Retail Pharmacy Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Drug Stores Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Others Consumption and Growth Rate (2017-2022)
10 Global Oral Solid Dosage Pharmaceutical Formulation Market Outlook by Types and Applications to 2028
-
10.1 Global Oral Solid Dosage Pharmaceutical Formulation Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Immediate Release Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Extended Release Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Oral Solid Dosage Pharmaceutical Formulation Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospital Pharmacy Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Retail Pharmacy Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Drug Stores Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Others Consumption Forecast and Growth Rate (2022-2028)
11 Global Oral Solid Dosage Pharmaceutical Formulation Import and Export Analysis (Top 5 Countries)
-
11.1 Global Oral Solid Dosage Pharmaceutical Formulation Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Oral Solid Dosage Pharmaceutical Formulation Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Oral Solid Dosage Pharmaceutical Formulation Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Oral Solid Dosage Pharmaceutical Formulation Market Competitive Analysis
-
14.1 Gilead
-
14.1.1 Gilead Company Details
-
14.1.2 Gilead Oral Solid Dosage Pharmaceutical Formulation Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Gilead Oral Solid Dosage Pharmaceutical Formulation Product and Service
-
14.2 AbbVie
-
14.2.1 AbbVie Company Details
-
14.2.2 AbbVie Oral Solid Dosage Pharmaceutical Formulation Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 AbbVie Oral Solid Dosage Pharmaceutical Formulation Product and Service
-
14.3 AstraZeneca
-
14.3.1 AstraZeneca Company Details
-
14.3.2 AstraZeneca Oral Solid Dosage Pharmaceutical Formulation Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 AstraZeneca Oral Solid Dosage Pharmaceutical Formulation Product and Service
-
14.4 Eli Lilly
-
14.4.1 Eli Lilly Company Details
-
14.4.2 Eli Lilly Oral Solid Dosage Pharmaceutical Formulation Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Eli Lilly Oral Solid Dosage Pharmaceutical Formulation Product and Service
-
14.5 Novartis
-
14.5.1 Novartis Company Details
-
14.5.2 Novartis Oral Solid Dosage Pharmaceutical Formulation Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Novartis Oral Solid Dosage Pharmaceutical Formulation Product and Service
-
14.6 Pfizer
-
14.6.1 Pfizer Company Details
-
14.6.2 Pfizer Oral Solid Dosage Pharmaceutical Formulation Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Pfizer Oral Solid Dosage Pharmaceutical Formulation Product and Service
-
14.7 Merck
-
14.7.1 Merck Company Details
-
14.7.2 Merck Oral Solid Dosage Pharmaceutical Formulation Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Merck Oral Solid Dosage Pharmaceutical Formulation Product and Service
-
14.8 Boehringer Ingelheim
-
14.8.1 Boehringer Ingelheim Company Details
-
14.8.2 Boehringer Ingelheim Oral Solid Dosage Pharmaceutical Formulation Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Boehringer Ingelheim Oral Solid Dosage Pharmaceutical Formulation Product and Service
-
14.9 Bristol-Myers Squibb
-
14.9.1 Bristol-Myers Squibb Company Details
-
14.9.2 Bristol-Myers Squibb Oral Solid Dosage Pharmaceutical Formulation Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Bristol-Myers Squibb Oral Solid Dosage Pharmaceutical Formulation Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Oral Solid Dosage Pharmaceutical Formulation
-
Figure Oral Solid Dosage Pharmaceutical Formulation Picture
-
Table Global Oral Solid Dosage Pharmaceutical Formulation Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Oral Solid Dosage Pharmaceutical Formulation Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Oral Solid Dosage Pharmaceutical Formulation Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Oral Solid Dosage Pharmaceutical Formulation Consumption by Country (2017-2022)
-
Figure United States Oral Solid Dosage Pharmaceutical Formulation Consumption and Growth Rate (2017-2022)
-
Table Europe Oral Solid Dosage Pharmaceutical Formulation Consumption and Growth Rate (2017-2022)
-
Figure China Oral Solid Dosage Pharmaceutical Formulation Consumption and Growth Rate (2017-2022)
-
Figure Japan Oral Solid Dosage Pharmaceutical Formulation Consumption and Growth Rate (2017-2022)
-
Figure India Oral Solid Dosage Pharmaceutical Formulation Consumption and Growth Rate (2017-2022)
-
Figure South Korea Oral Solid Dosage Pharmaceutical Formulation Consumption and Growth Rate (2017-2022)
-
Figure Global Oral Solid Dosage Pharmaceutical Formulation Consumption Forecast by Country (2022-2028)
-
Figure United States Oral Solid Dosage Pharmaceutical Formulation Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Oral Solid Dosage Pharmaceutical Formulation Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Oral Solid Dosage Pharmaceutical Formulation Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Oral Solid Dosage Pharmaceutical Formulation Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Oral Solid Dosage Pharmaceutical Formulation Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Oral Solid Dosage Pharmaceutical Formulation Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Immediate Release Consumption and Growth Rate (2017-2022)
-
Figure Global Extended Release Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Pharmacy Consumption and Growth Rate (2017-2022)
-
Figure Global Retail Pharmacy Consumption and Growth Rate (2017-2022)
-
Figure Global Drug Stores Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Immediate Release Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Extended Release Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Pharmacy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Retail Pharmacy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Drug Stores Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Oral Solid Dosage Pharmaceutical Formulation Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Oral Solid Dosage Pharmaceutical Formulation Export by Region (Top 5 Countries) (2017-2028)
-
Table Gilead (Foundation Year, Company Profile and etc.)
-
Table Gilead Oral Solid Dosage Pharmaceutical Formulation Sales, Price, Value and Gross Profit (2017-2022)
-
Table Gilead Oral Solid Dosage Pharmaceutical Formulation Product and Service
-
Table AbbVie (Foundation Year, Company Profile and etc.)
-
Table AbbVie Oral Solid Dosage Pharmaceutical Formulation Sales, Price, Value and Gross Profit (2017-2022)
-
Table AbbVie Oral Solid Dosage Pharmaceutical Formulation Product and Service
-
Table AstraZeneca (Foundation Year, Company Profile and etc.)
-
Table AstraZeneca Oral Solid Dosage Pharmaceutical Formulation Sales, Price, Value and Gross Profit (2017-2022)
-
Table AstraZeneca Oral Solid Dosage Pharmaceutical Formulation Product and Service
-
Table Eli Lilly (Foundation Year, Company Profile and etc.)
-
Table Eli Lilly Oral Solid Dosage Pharmaceutical Formulation Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eli Lilly Oral Solid Dosage Pharmaceutical Formulation Product and Service
-
Table Novartis (Foundation Year, Company Profile and etc.)
-
Table Novartis Oral Solid Dosage Pharmaceutical Formulation Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis Oral Solid Dosage Pharmaceutical Formulation Product and Service
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer Oral Solid Dosage Pharmaceutical Formulation Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Oral Solid Dosage Pharmaceutical Formulation Product and Service
-
Table Merck (Foundation Year, Company Profile and etc.)
-
Table Merck Oral Solid Dosage Pharmaceutical Formulation Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck Oral Solid Dosage Pharmaceutical Formulation Product and Service
-
Table Boehringer Ingelheim (Foundation Year, Company Profile and etc.)
-
Table Boehringer Ingelheim Oral Solid Dosage Pharmaceutical Formulation Sales, Price, Value and Gross Profit (2017-2022)
-
Table Boehringer Ingelheim Oral Solid Dosage Pharmaceutical Formulation Product and Service
-
Table Bristol-Myers Squibb (Foundation Year, Company Profile and etc.)
-
Table Bristol-Myers Squibb Oral Solid Dosage Pharmaceutical Formulation Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bristol-Myers Squibb Oral Solid Dosage Pharmaceutical Formulation Product and Service
-
